These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33535104)

  • 1. Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody.
    Kim SI; Kim S; Shim JM; Lee HJ; Chang SY; Park S; Min JY; Park WB; Oh MD; Kim S; Chung J
    Biochem Biophys Res Commun; 2021 Mar; 545():33-39. PubMed ID: 33535104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model.
    Niu X; Zhao L; Qu L; Yao Z; Zhang F; Yan Q; Zhang S; Liang R; Chen P; Luo J; Xu W; Lv H; Liu X; Lei H; Yi C; Li P; Wang Q; Wang Y; Yu L; Zhang X; Bryan LA; Davidson E; Doranz JB; Feng L; Pan W; Zhang F; Chen L
    Emerg Microbes Infect; 2019; 8(1):749-759. PubMed ID: 31130109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein.
    Bailey MJ; Broecker F; Freyn AW; Choi A; Brown JA; Fedorova N; Simon V; Lim JK; Evans MJ; García-Sastre A; Palese P; Tan GS
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31043537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zika Virus Envelope Protein and Antibody Complexes.
    Dai L; Wang Q; Song H; Gao GF
    Subcell Biochem; 2018; 88():147-168. PubMed ID: 29900496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
    Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J
    Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.
    Long F; Doyle M; Fernandez E; Miller AS; Klose T; Sevvana M; Bryan A; Davidson E; Doranz BJ; Kuhn RJ; Diamond MS; Crowe JE; Rossmann MG
    Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1591-1596. PubMed ID: 30642974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
    Tharakaraman K; Watanabe S; Chan KR; Huan J; Subramanian V; Chionh YH; Raguram A; Quinlan D; McBee M; Ong EZ; Gan ES; Tan HC; Tyagi A; Bhushan S; Lescar J; Vasudevan SG; Ooi EE; Sasisekharan R
    Cell Host Microbe; 2018 May; 23(5):618-627.e6. PubMed ID: 29746833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
    Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.
    Tai W; He L; Wang Y; Sun S; Zhao G; Luo C; Li P; Zhao H; Fremont DH; Li F; Jiang S; Zhou Y; Du L
    Emerg Microbes Infect; 2018 Jan; 7(1):7. PubMed ID: 29362446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc
    Yu L; Liu X; Ye X; Su W; Zhang X; Deng W; Luo J; Xiang M; Guo W; Zhang S; Xu W; Yan Q; Wang Q; Cui Y; Wu C; Guo W; Niu X; Zhang F; Lei C; Qu L; Chen L; Feng L
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
    Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of two human monoclonal antibodies limits fetal damage by Zika virus in macaques.
    Van Rompay KKA; Coffey LL; Kapoor T; Gazumyan A; Keesler RI; Jurado A; Peace A; Agudelo M; Watanabe J; Usachenko J; Singapuri A; Immareddy R; Ardeshir A; Stuart JB; Bournazos S; Ravetch JV; Balderes PJ; Lorenz IC; Esswein SR; Keeffe JR; Bjorkman PJ; Wang Q; Rice CM; MacDonald MR; Nussenzweig MC; Robbiani DF
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7981-7989. PubMed ID: 32209664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge.
    Zhao H; Xu L; Bombardi R; Nargi R; Deng Z; Errico JM; Nelson CA; Dowd KA; Pierson TC; Crowe JE; Diamond MS; Fremont DH
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.
    Stettler K; Beltramello M; Espinosa DA; Graham V; Cassotta A; Bianchi S; Vanzetta F; Minola A; Jaconi S; Mele F; Foglierini M; Pedotti M; Simonelli L; Dowall S; Atkinson B; Percivalle E; Simmons CP; Varani L; Blum J; Baldanti F; Cameroni E; Hewson R; Harris E; Lanzavecchia A; Sallusto F; Corti D
    Science; 2016 Aug; 353(6301):823-6. PubMed ID: 27417494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the immunogenicity of Zika glycan loop.
    Henderson EA; Tam CC; Cheng LW; Ngono AE; Nguyen AV; Shresta S; McGee M; Padgett H; Grill LK; Martchenko Shilman M
    Virol J; 2020 Mar; 17(1):43. PubMed ID: 32234060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine protection against Zika virus from Brazil.
    Larocca RA; Abbink P; Peron JP; Zanotto PM; Iampietro MJ; Badamchi-Zadeh A; Boyd M; Ng'ang'a D; Kirilova M; Nityanandam R; Mercado NB; Li Z; Moseley ET; Bricault CA; Borducchi EN; Giglio PB; Jetton D; Neubauer G; Nkolola JP; Maxfield LF; De La Barrera RA; Jarman RG; Eckels KH; Michael NL; Thomas SJ; Barouch DH
    Nature; 2016 Aug; 536(7617):474-8. PubMed ID: 27355570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody.
    Esswein SR; Gristick HB; Jurado A; Peace A; Keeffe JR; Lee YE; Voll AV; Saeed M; Nussenzweig MC; Rice CM; Robbiani DF; MacDonald MR; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2020 May; 117(18):9865-9875. PubMed ID: 32321830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
    Graham SD; Tu HA; McElvany BD; Graham NR; Grinyo A; Davidson E; Doranz BJ; Diehl SA; de Silva AM; Markmann AJ
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.